Document
  • Global Full-Service CRO & Biologics CDMO

    Supporting drug development with global clinical research services and biologics CDMO solutions.

  • Phase I to Phase IV Clinical Development

    Backed by decades of clinical research experience, our integrated CRO capabilities combine scientific, operational, laboratory, and regulatory expertise across every phase of clinical development.

  • Therapeutic Expertise Across Diverse Indications

    Extensive therapeutic expertise across diverse indications, backed by experience from 300+ late-phase clinical trials.

  • Global Reach. Local Expertise. Seamless Trial Execution.

    With operations across India, USA, Canada, UK, Spain, and Poland, Lambda brings local expertise and global reach to every clinical trial program.

  • Paving the Path to Regulatory Success

    Navigating global regulatory frameworks with a proven compliance track record, enabling smooth submissions and consistent compliance for your clinical programs.

Capabilities

Comprehensive CRO capabilities spanning early to late-phase clinical development, supported by global operations, scientific expertise, and regulatory alignment.

Accelerating Biosimilar Development

Lambda holds a strong legacy in biosimilar development, covering a broad portfolio of molecules such as Adalimumab, Bevacizumab, Denosumab, Pertuzumab, Rituximab, Daratumumab, Trastuzumab, Trastuzumab Emtansine, Vedolizumab, Ranibizumab, Teriparatide, Aflibercept, Filgrastim, and Pegfilgrastim.

End-to-End Solutions

Full-service CRO Capabilities 

Analytical Excellence

State-of-the-art lab with ELISA, ECLIA, IVD, Flow Cytometry and More

Accelerating Biosimilar Development - CRO CDMO - Lambda

Accelerating Biosimilar Development

Lambda holds a strong legacy in biosimilar development, covering a broad portfolio of molecules such as Adalimumab, Bevacizumab, Denosumab, Pertuzumab, Rituximab, Daratumumab, Trastuzumab, Trastuzumab Emtansine, Vedolizumab, Ranibizumab, Aflibercept, Teriparatide, Filgrastim, and Pegfilgrastim.

End-to-End Solutions

Full-service offerings from Preclinical to Regulatory Support

Analytical Excellence

State-of-the-art lab with ELISA, ECLIA, IVD, Flow Cytometry & More

Biosimiar Home Page 1 scaled

Why Lambda?

We bring together integrated capabilities and global operations to support biotech and pharmaceutical companies across clinical development and resource support needs.

A Global CRO with Operations across Continents

Full-Spectrum Clinical Research Services

Strong Credit Rating in the CRO Industry

Experienced Leadership team with Strong Industry Expertise

A Truly Global CRO with Multi-continental Presence

Comprehensive Clinical Research Services

Best Credit rating in CRO Industry

Strong Leadership with 20+ years of Experience

PK/PD Studies
0 +
Late-Phase Trials
0 +
Validated Assays
0 +
Professionals
0 +
CPHI Award Badges

‘Regulatory & Compliance Excellence Award’ at the CPHI Pharma Awards 2023 for the exceptional work by Lambda in ‘Enhancing Compliance & Data Generation in Clinical Trials through Advanced Software Solutions and EDC Platform.’

GGB Award Badges

‘Industry Partner of the Year’ Award

Global Generics & Biosimilar Awards 2023

Featured Research and Insights

Our Presence

We are aggressively expanding globally and are confident in our research initiatives, propelling us toward a trajectory of excellence.

Lambda Novum Global Locations

Corporate Office – Ahmedabad

Lambda House, Plot No. 38,
Survey No. 388,
Near Silver Oak University,
S.G. Highway, Gota, Ahmedabad - 382481,
Gujarat, India.

Representative Office 

Poland (Warsaw)

Representative Office 

UK (London)

Representative Office 

Canada (Toronto)

Representative Office 

US (Las Vegas)

Representative Office 

Spain (Barcelona)